Uncategorized


November 11, 2026

(ASML, TOELF, NVDA, AMD) NDAA: 65% Chance Congress Adopts Three Semiconductor Export Control Measures

By Joe Lieber

We now assign 65% odds the MATCH Act, Chip Security Act, and the AI OVERWATCH Act all become law before Christmas, potentially imposing significant new restrictions on semiconductor equipment and advanced AI chip exports to…

Read More >>

November 9, 2026

[UNH, CI, CVS, ELV, HUM] Healthcare Conglomerates: Democratic Sweep Heightens Breakup Risk but Doesn’t Fully Remove Hurdles

By Beth Steindecker

The prospects for federal legislation forcing health insurers and pharmacy benefit managers (PBMs) [UNH, CI, CVS, ELV, HUM] to divest their pharmacies or healthcare providers have increased following Democrats’ sweeping midterm victories. While we expected…

Read More >>

November 9, 2026

Capitol Policy Weekly: Congress Returns, Permitting Reform, Chip Export Controls, the NDAA and the Lame Duck

By Joe Lieber

The House and Senate return to Washington this week, with members still digesting the ramifications of last Tuesday’s Democratic blowout in the midterm elections. President Trump’s decision to replace Susie Wiles with Stephen Miller as…

Read More >>

November 6, 2026

(AMZN, COST, KR, DAL, UAL, JBLU, UBER, LYFT, DASH, CART, WMT, TGT) Surveillance Pricing in the Crosshairs

By Joe Lieber

One issue that has flown under the radar screen but that we expect congressional Democrats to further scrutinize next year is surveillance pricing, also known as personalized pricing. We expect legislation such as Sen. Ruben…

Read More >>

November 5, 2026

[PNTG, BTSG, AVAH, ADUS, UNH, HUM] Home Health: CY27 Final Rule Preserves Stable Rates, Offers Limited Additional Relief

By Beth Steindecker

Home health (HH) agencies [PNTG, BTSG, AVAH, ADUS, UNH, HUM, AccentCare, Elara, Compassus] received a largely expected favorable outcome in CMS’s final CY27 Medicare HH payment rule. This reinforces our view that the industry has…

Read More >>

November 5, 2026

(CHTR, CMCSA, T, VZ, TMUS) Could Democrats Revive the Affordability Connectivity Program (ACP) Through the Highway Bill?

By Joe Lieber

With Democrats having retaken the House and the Senate, we believe they are likely to attempt to revive the Affordable Connectivity Program (ACP), which would benefit Charter Communications (CHTR), Comcast (CMCSA), AT&T (T), Verizon (VZ),…

Read More >>

November 5, 2026

GKOS: Rate Rules Signaling iDose Pressures?

By John Leppard

CMS finalized its CY27 facility rates for Glaukos (GKOS) – and other ophthalmology services – largely as proposed, but two associated dynamics strike us as noteworthy for investors: iDose Combo Volumes: Agency hospital outpatient department…

Read More >>

November 5, 2026

[HCA, THC, CYH, ARDT, SGRY, RDNT, LMRI, OPCH] Final OPPS: Modest 340B Relief but For-Profits Still Benefit Even with Imaging Site Neutrality

By Beth Steindecker

CMS’s final CY27 Medicare hospital outpatient prospective payment system (OPPS) rule disproportionately favorable for for-profit hospital outpatient departments (HOPDs) [HCA, THC, CYH, ARDT, UHS] while nonprofit and government-owned hospitals with substantial 340B drug exposure face…

Read More >>

November 4, 2026

(MSFT, AMZN, GOOGL, META, ORCL, CRWV, EQIX, DLR, NVDA, AMD) Why the Political Backlash Against Data Centers Won’t End with the Midterms

By Joe Lieber

We believe investors expecting the political controversy surrounding AI and data centers to subside following the midterm elections are likely to be disappointed. Opposition to data centers has become a bipartisan political issue, and we…

Read More >>

November 4, 2026

What the Democrat Blue Wave Means for the Markets: Our First Thoughts

By Joe Lieber

As we go to press, Democrats appear on track to gain at least 35 House seats, giving likely incoming Speaker Hakeem Jeffries (D-NY) considerable room to maneuver and limiting the leverage of the roughly seven…

Read More >>